Red blood cell immunization programs
Download
1 / 31

Red Blood Cell Immunization Programs - PowerPoint PPT Presentation


  • 771 Views
  • Uploaded on

Red Blood Cell Immunization Programs Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009 Outline RBC Immunization Processes Source Plasma (donor and product) RBCs (donor and product) Immunogen RBC qualification and preparation RBC immunization procedures

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Red Blood Cell Immunization Programs' - liam


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Red blood cell immunization programs l.jpg

Red Blood Cell Immunization Programs

Judy Ellen Ciaraldi

BS, MT(ASCP)SBB, CQA(ASQ)

CBER, OBRR, DBA

September 16, 2009


Outline l.jpg
Outline

  • RBC Immunization Processes

    • Source Plasma (donor and product)

    • RBCs (donor and product)

    • Immunogen RBC qualification and preparation

    • RBC immunization procedures

  • Considerations on how to submit for a RBC immunization program

  • CBER review of RBC immunization programs


Source plasma donor l.jpg
Source Plasma Donor

  • Must meet all donor suitability criteria in 640.63, 640.65, and 610.40

    • Physical examination within 1 week before first immunization(640.63(b)(2)) unless active donor

  • Should not have child-bearing capability

    • Male

    • Female who is post-menopausal or surgically sterile

  • Tested for RBC antigen profile

    • D, C, E, c, e, K, Fya, others as needed


Source plasma donor cont l.jpg
Source Plasma Donor(cont.)

  • If donors elicit no response (no antibodies develop), they can return to normal Source Plasma donor pool if they meet normal donor suitability criteria

    • Deferred for 12 months after last injection (640.63(c)(13)) unless…

    • Documented proof that only qualified cells were injected

    • Request for an alternative procedure under 640.120 to donate in less than 12 months has been approved


Source plasma product l.jpg
Source Plasma Product

  • Contains high titer of RBC antibody

  • Made into injectable and noninjectable products

  • Must meet standards for normal Source Plasma

    • 640.64 & 640.69 – Collection and storage

    • 640.70 & 640.76 – Storage and shipping temps; labeling

    • 610.40 – Infectious disease testing

  • Label must state the immunizing antigen or specific antibody present(640.70(a)(7))


Donors of immunogen red blood cells l.jpg
Donors of ImmunogenRed Blood Cells

  • Must meet all Whole Blood donor suitability criteria (640.3 and 610.40)

  • Must not have been transfused within previous 12 months (640.3(c)(3))

  • Should be available for infectious disease testing for the qualification process

  • May also be a Source Plasma donor

    • Track RBC and plasma volumes donated or lost

    • Track donation intervals


Whole blood collection l.jpg
Whole Blood Collection

  • Procedures must be consistent with 640.4

  • Volumes and frequency must not exceed those for routine Whole Blood donations (640.3)

  • If implementing Whole Blood collection in Source Plasma center, report to FDA as follows:

    • PAS – Using new SOPs for donor selection and collection

    • AR – Using previously approved SOPs

    • Blood establishment registration form updated to include Whole Blood collection


Whole blood red blood cells l.jpg
Whole Blood/Red Blood Cells

  • Must meet standards for Whole Blood

    • 600.15, 610.53, 640.5 – Storage and shipping temps, processing

    • 610.40 – Infectious disease testing

  • With FDA approval, may ship to lab before testing completed (610.40(g))

    • Label unit with tests completed and pending (606.121(h))

  • These blood components need not be licensed if collected as part of approved RBC immunization program

    • Label contains applicant name, address, collection facility registration number (606.121.(c))

    • No license number on Whole Blood/Red Blood Cells


Whole blood red blood cells cont l.jpg
Whole Blood/Red Blood Cells(cont.)

  • Tested for RBC antigen profile

    • D, C, E, c, e, K, Fya, others as needed

  • Storage:

    • Liquid – 1-6 C (shelf life determined by anticoagulant)

    • Frozen - -65 C or colder for up to 10 years

    • Deglycerolized – 1-6 C for approved shelf life based on sterility data


Immunogen rbc qualifying process l.jpg
Immunogen RBC Qualifying Process

  • Test new RBC donors for all infectious diseases in 610.40

  • If negative, freeze RBC for 12 months

  • After 12 months, retest RBC donor

  • If negative, inject deglycerolized RBCs into no more than 3 acceptable Source Plasma donors

  • Test Source Plasma donors for infectious diseases at 3, 6, 9 and 12 months after immunization

  • If Source Plasma (SP) donors are negative, RBCs are qualified to be used to immunize other SP donors


New rbc donors l.jpg

Test potential donor for all infectious disease markers

NR

Collect RBCs and store frozen for 12 months

Test donor and intended recipients for all markers

NR

Immunize up to 3 Recipients

Test recipients at 3, 6, 9, 12 months for all markers

NR

Frozen cells qualified for routine use – Donor is “pedigreed”

NEW RBC DONORS


Qualified pedigreed rbc donors l.jpg

Test donor for all infectious disease markers

NR

Collect RBCs and store frozen for 12 months

Retest donor for all infectious disease markers

NR

Frozen Red Blood Cells qualified for routine use

QUALIFIED (PEDIGREED) RBC DONORS


Preparation of immunogen rbcs l.jpg
Preparation of Immunogen RBCs

  • RBCs glycerolized and frozen

  • RBCs thawed and deglycerolized

  • Sterility testing done on 1 sample from each lot

  • Aseptically aliquoted into sterile, pyrogen-free single-dose labeled vials

  • Shipped to Source Plasma donor; visually inspected

  • RBCs drawn into syringe


Rbc immunization procedure l.jpg
RBC Immunization Procedure

  • De Novo (donors who do not have pre-existing RBC antibodies) immunization only allowed for anti-D

    • Maximum 50 mL in 4 month period

    • Donor not responding after 150 mL should be dropped

  • Re-stimulation (boost) of pre-existing antibody

    • Maximum of 4 mL up to 5 times/month

    • Not to exceed 40 mL in 6 month period

  • Immunization only done with qualified RBCs

  • May immunize on same day as plasmapheresis, but only after plasmapheresis procedure

  • Physician (or trained individual) can do injections


Submitting rbc immunization programs l.jpg
Submitting RBC Immunization Programs

  • RBC immunization programs have been approved by CBER

    • PAS supplement

    • Pre-approval inspections

  • RBC immunization programs are “site-specific” approvals

  • Contractual arrangements are possible

    • Perform injections

    • Collect plasma

    • Supply Whole Blood and/or immunogen RBCs


Submission content l.jpg
Submission Content

  • Forms: 356h and 2567

  • Applicant name and license number

  • Contact name and information

  • Facility name, address and registration number

  • Contractor information

  • Medical oversight


Submission content cont l.jpg
Submission Content (cont.)

  • Informed consent form (640.61 & 640.72(a)(3))

  • RBC immunization program SOPs

  • Immunization records for 5 donors

  • Sterility data for 10 lots

    • Support deglycerolized RBC expiration date

  • Labels

  • May reference previously approved SOPs, forms, labels

    • Include approved reference number


Contractor information l.jpg
Contractor Information

  • Name and license number

  • Address and registration number

  • List of activities done under contract

  • Where records are maintained

  • Describe quality oversight of contractor

  • Contract manufacturers must be registered and licensed in many cases

    • Exception: Sterility testing lab exempt from registration


Medical supervision of rbc immunization program l.jpg
Medical Supervision of RBC Immunization Program

  • Physician must: (640.66)

    • Certify the donor’s health to participate

    • Administer the informed consent

    • Approve injection schedule

    • Select the antigen to be injected

    • Evaluate clinical response (including monitoring reactions)

  • Physician must be on premises during RBC immunization (640.62)

  • Keep donor at center after immunization to observe for immediate reactions


Informed consent l.jpg
Informed Consent

  • Volume, route and schedule of injections

  • Criteria for discontinuation from program

  • Participate in only one immunization program at a time

  • May not be eligible for other donation programs

  • Possible adverse reactions

    • May develop unexpected antibodies that cause delays in obtaining compatible blood for transfusions

  • Restrictions for female participants


Slide21 l.jpg
SOPs

  • Immunization procedures must be on file at centers where immunizations are performed (640.66)

  • Medical oversight, responsibilities

  • Evaluation of clinical responses and adverse reactions

  • Whole Blood and Source Plasma donor selection procedures and testing

    • Criteria for participation in and discontinuation from program


Sops cont l.jpg
SOPs (cont.)

  • Whole Blood collection and preparation of immunogen RBCs

    • Immunogen RBC qualification

    • Sterility testing

    • Aliquoting

    • Quality control procedures

    • Freezing and deglycerolizing

  • Transport/ship immunogen RBCs to Source Plasma donor


Sops cont23 l.jpg
SOPs (cont.)

  • Evaluation of immunogen RBCs received from supplier

  • Immunization procedures

    • Physician approval

    • Preparation of injection

    • Injection volume and schedule, administration route

    • When titrations will be performed

    • Handling and storing of vials (1-6 C)

  • Monitor for unexpected antibodies (e.g., additional antibodies)

  • Proper documentation procedures


Immunization records l.jpg
Immunization Records

  • Donor name, ID number

  • Injection preparation – date, employee name, visual inspection

  • Injection – date, employee name, route, volume

  • Immunogen RBCs – lot number, expiration date

  • Physician approval

    • Selection of immunogen RBCs

    • Injection – date and volume


Immunization records cont l.jpg
Immunization Records (cont.)

  • Adverse reactions (640.72(d))

  • Antibody name, test results and titers

    • Unexpected antibodies (e.g., additional antibodies)

  • ABO group, Rh type and RBC phenotyping


Other records 606 160 640 72 l.jpg
Other Records (606.160 & 640.72)

  • Whole Blood and Source Plasma donor selection and testing

  • Informed consent for immunization (640.61, 640.72(a)(3))

  • Freezing and deglycerolizing, including quality control tests

  • Ongoing sterility test results

  • Trace immunogen RBCs to Whole Blood donor


Other records cont l.jpg
Other Records(cont.)

  • Storage and shipping temperatures

  • Collection procedures

    • Volume

    • RBC loss

    • Donation reactions

  • Immunogen RBC qualification procedures

  • Evidence of review done to identify and correct deficiencies (606.100(c))


Cber review of rbc immunization programs l.jpg
CBER Review of RBC Immunization Programs

  • Based on desk review and inspection

  • Donor selection consistent with applicable regulations and guidance documents

  • SOPs include all critical procedures

    • Medical oversight

  • Informed consent includes recommendations in guidance document

  • Forms contain all information and show evidence of QA review


Cber review of rbc immunization programs cont l.jpg
CBER Review of RBC Immunization Programs (cont.)

  • All facilities (including contractors) are FDA registered and licensed when required, and have acceptable compliance checks

  • Labels consistent with 640.70

    • Include immunizing antigen

  • Pre-approval inspection scheduled after desk review

    • Observe operations are consistent with SOPs and regulations

    • Observe all procedures requested in submission


References l.jpg
References

  • Blood memorandum: Revised Recommendations for Red Blood Cells Immunization Programs for Source Plasma Donors (3/14/95)

    • http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/OtherRecommendationsforManufacturers/MemorandumtoBloodEstablishments/default.htm

  • Guidelines for Immunization of Source Plasma (Human) Donors with Blood Substances (6/80)

    • http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/default.htm


References cont l.jpg
References (cont.)

  • Guidance for Industry: Informed Consent Recommendations for Source Plasma Donors Participating in Plasmapheresis and Immunization Programs (8/8/07)

    • http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm073433.htm


ad